Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

TVTXTVTX
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in TRAVERE THERAPEUTICS INC

Yes. Vanguard Portfolio Management holds 1,541,617 shares of TVTX (Travere Therapeutics), worth $87.6M, as of its Q2 2026 13F filing. It reduced the position by 167,522 shares (-9.8%) from Q1 2026. Vanguard Portfolio Management has held TVTX in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$87.6M

Current Shares

1.5M

Total Value Change

+$36.8M

Total Shares Change

-167,522

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-9.8%
$87.6M0.0%$56.81
0
2026-Q1
First report
1.7M
-
$50.8M0.0%$29.71
0

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used